TherapeuticsMD, Inc. (TXMD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.13
+2.90%
Mkt Cap $26.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $19.77M | $893.00K | -95.48% | -$6.13 | -$0.05 | +99.12% | — | — |
| Q4 2025 Nov 12, 2025 | — | $784.00K | — | — | $0.01 | — | — | — |
| Q3 2025 Aug 12, 2025 | — | $952.00K | — | — | $0.05 | — | — | — |
| Q2 2025 May 13, 2025 | — | $393.00K | — | — | -$0.06 | — | — | — |
| Q1 2025 Mar 27, 2025 | $2.30M | $667.00K | -71.00% | $0.04 | $0.02 | -45.38% | — | — |
| Q4 2024 Nov 12, 2024 | $2.30M | $547.00K | -76.22% | $0.04 | -$0.05 | -225.00% | — | — |
| Q3 2024 Aug 12, 2024 | $500.00K | $234.00K | -53.20% | $0.03 | -$0.09 | -400.00% | — | — |
| Q2 2024 May 10, 2024 | $500.00K | $313.00K | -37.40% | $0.03 | -$0.07 | -333.33% | — | — |
| Q1 2024 Mar 29, 2024 | $500.00K | $502.00K | +0.40% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q4 2023 Nov 14, 2023 | $500.00K | -$53.00K | -110.60% | -$0.15 | -$0.13 | +13.33% | — | — |
| Q3 2023 Aug 14, 2023 | $500.00K | $437.00K | -12.60% | -$0.07 | -$0.24 | -242.86% | — | — |
| Q2 2023 May 15, 2023 | $1.70M | $416.00K | -75.53% | $0.06 | -$0.24 | -500.00% | — | — |
| Q1 2023 Mar 27, 2023 | $23.80M | $1.15M | -95.16% | -$1.11 | -$3.55 | -219.55% | — | — |
| Q4 2022 Nov 14, 2022 | $26.80M | $20.92M | -21.95% | -$2.04 | -$3.13 | -53.43% | — | — |
| Q3 2022 Aug 15, 2022 | $23.20M | $28.56M | +23.11% | -$3.04 | -$2.15 | +29.28% | — | — |
| Q2 2022 May 16, 2022 | $17.95M | $19.33M | +7.67% | -$3.50 | -$4.72 | -34.86% | — | — |
| Q1 2022 Mar 10, 2022 | $29.39M | $18.68M | -36.45% | -$3.00 | -$4.50 | -50.00% | — | — |
| Q4 2021 Nov 11, 2021 | $25.87M | $25.41M | -1.80% | -$5.00 | -$5.50 | -10.00% | — | — |
| Q3 2021 Aug 4, 2021 | $23.00M | $23.00M | +0.00% | -$5.50 | -$5.50 | +0.00% | — | — |
| Q2 2021 May 6, 2021 | $21.52M | $19.87M | -7.69% | -$5.00 | -$5.50 | -10.00% | — | — |